1.22
-0.015(-1.22%)
Currency In USD
| Previous Close | 1.23 |
| Open | 1.2 |
| Day High | 1.27 |
| Day Low | 1.2 |
| 52-Week High | 11.76 |
| 52-Week Low | 0.94 |
| Volume | 21,117 |
| Average Volume | 248,625 |
| Market Cap | 58M |
| PE | -0.83 |
| EPS | -1.46 |
| Moving Average 50 Days | 1.17 |
| Moving Average 200 Days | 3.73 |
| Change | -0.02 |
If you invested $1000 in Shattuck Labs, Inc. (STTK) since IPO date, it would be worth $62.79 as of February 05, 2025 at a share price of $1.215. Whereas If you bought $1000 worth of Shattuck Labs, Inc. (STTK) shares 3 years ago, it would be worth $217.35 as of February 05, 2025 at a share price of $1.215.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Shattuck Labs Announces Poster Presentation at Upcoming 2025 Crohn’s and Colitis Congress
GlobeNewswire Inc.
Yesterday at 12:00 PM GMT
AUSTIN, TX and DURHAM, NC, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the
Shattuck Labs Announces Presentation at the 43rd Annual J.P. Morgan Healthcare Conference
GlobeNewswire Inc.
Jan 06, 2025 9:59 PM GMT
AUSTIN, TX and DURHAM, NC, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the
Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2025
GlobeNewswire Inc.
Jan 02, 2025 12:00 PM GMT
AUSTIN, TX and DURHAM, NC, Jan. 02, 2025 (GLOBE NEWSWIRE) -- Shattuck Labs, Inc. (Shattuck) (NASDAQ: STTK), a biotechnology company pioneering the development of novel therapeutics targeting tumor necrosis factor (TNF) superfamily receptors for the